Caprock Group’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
$2.53M Buy
34,444
+6,715
+24% +$494K 0.08% 230
2024
Q4
$1.82M Buy
27,729
+3,600
+15% +$236K 0.06% 287
2024
Q3
$1.88M Buy
24,129
+87
+0.4% +$6.78K 0.07% 245
2024
Q2
$1.88M Buy
24,042
+13,592
+130% +$1.06M 0.08% 222
2024
Q1
$708K Buy
10,450
+1,239
+13% +$83.9K 0.04% 319
2023
Q4
$620K Sell
9,211
-1,896
-17% -$128K 0.04% 340
2023
Q3
$752K Buy
11,107
+262
+2% +$17.7K 0.06% 264
2023
Q2
$776K Buy
10,845
+625
+6% +$44.7K 0.06% 265
2023
Q1
$709K Buy
10,220
+1,711
+20% +$119K 0.06% 270
2022
Q4
$577K Sell
8,509
-24
-0.3% -$1.63K 0.05% 255
2022
Q3
$468K Sell
8,533
-929
-10% -$51K 0.05% 289
2022
Q2
$625K Sell
9,462
-181
-2% -$12K 0.06% 228
2022
Q1
$640K Buy
9,643
+3,015
+45% +$200K 0.06% 246
2021
Q4
$386K Sell
6,628
-1,926
-23% -$112K 0.03% 350
2021
Q3
$514K Buy
8,554
+2,438
+40% +$146K 0.05% 251
2021
Q2
$366K Sell
6,116
-5,493
-47% -$329K 0.03% 309
2021
Q1
$577K Sell
11,609
-673
-5% -$33.5K 0.06% 217
2020
Q4
$614K Buy
12,282
+2,211
+22% +$111K 0.07% 204
2020
Q3
$552K Buy
10,071
+1,127
+13% +$61.8K 0.08% 188
2020
Q2
$473K Sell
8,944
-163
-2% -$8.62K 0.07% 203
2020
Q1
$407K Buy
9,107
+2,695
+42% +$120K 0.08% 181
2019
Q4
$320K Buy
6,412
+138
+2% +$6.89K 0.06% 237
2019
Q3
$280K Buy
6,274
+568
+10% +$25.3K 0.05% 249
2019
Q2
$236K Sell
5,706
-653
-10% -$27K 0.05% 272
2019
Q1
$257K Buy
6,359
+644
+11% +$26K 0.05% 288
2018
Q4
$217K Buy
+5,715
New +$217K 0.05% 297
2016
Q4
Sell
-10,800
Closed -$355K 347
2016
Q3
$355K Buy
10,800
+828
+8% +$27.2K 0.08% 227
2016
Q2
$301K Sell
9,972
-1,470
-13% -$44.4K 0.07% 212
2016
Q1
$322K Buy
+11,442
New +$322K 0.08% 217